Luciana C C Leite Selected Research

pneumococcal surface protein A

10/2017	A Combination of Recombinant Mycobacterium bovis BCG Strains Expressing Pneumococcal Proteins Induces Cellular and Humoral Immune Responses and Protects against Pneumococcal Colonization and Sepsis.
8/2017	Conjugation of PspA4Pro with Capsular Streptococcus pneumoniae Polysaccharide Serotype 14 Does Not Reduce the Induction of Cross-Reactive Antibodies.
1/2013	Characterization of protective immune responses induced by pneumococcal surface protein A in fusion with pneumolysin derivatives.
4/2008	Nasal immunization of mice with Lactobacillus casei expressing the Pneumococcal Surface Protein A: induction of antibodies, complement deposition and partial protection against Streptococcus pneumoniae challenge.
3/2008	Recognition of pneumococcal isolates by antisera raised against PspA fragments from different clades.
9/2002	Analysis of serum cross-reactivity and cross-protection elicited by immunization with DNA vaccines against Streptococcus pneumoniae expressing PspA fragments from different clades.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luciana C C Leite Research Topics

Disease

9	Infections 05/2022 - 02/2005
9	Pneumococcal Infections 01/2020 - 03/2006
7	Schistosomiasis (Bilharziasis) 03/2020 - 06/2004
6	Tuberculosis (Tuberculoses) 05/2022 - 08/2013
6	Whooping Cough (Pertussis) 01/2021 - 01/2004
5	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 11/2008
4	Inflammation (Inflammations) 05/2022 - 08/2010
4	Sepsis (Septicemia) 10/2017 - 06/2003
4	Reinfection 02/2010 - 11/2008
2	Diphtheria 01/2021 - 01/2004
2	Tetanus 01/2021 - 01/2004
2	Human Influenza (Influenza) 04/2013 - 06/2009
2	Weight Loss (Weight Reduction) 09/2010 - 11/2008
2	Neoplasms (Cancer) 09/2010 - 11/2008
1	Pulmonary Tuberculosis 01/2021
1	COVID-19 11/2020
1	Carcinoma in Situ 01/2019
1	Meningitis 04/2013
1	Japanese Encephalitis 04/2013
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 04/2013
1	Hepatitis E 04/2013
1	Hypersensitivity (Allergy) 01/2012
1	Asthma (Bronchial Asthma) 08/2010
1	Lung Diseases (Lung Disease) 08/2010
1	Parasitic Diseases (Parasitic Disease) 06/2009
1	Disease Resistance 06/2009
1	Acute Disease 10/2006
1	Leptospirosis 03/2005
1	Bacteremia 09/2002

Drug/Important Bio-Agent (IBA)

30	VaccinesIBA 05/2022 - 01/2004
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2009
6	pneumococcal surface protein AIBA 10/2017 - 09/2002
5	AntigensIBA 09/2010 - 09/2002
3	CytokinesIBA 05/2022 - 06/2009
3	Praziquantel (Biltricide)FDA Link 03/2020 - 10/2006
3	Pertussis ToxinIBA 01/2019 - 11/2008
3	AllergensIBA 01/2018 - 08/2010
3	AntibodiesIBA 01/2017 - 06/2003
2	Combined VaccinesIBA 01/2021 - 04/2013
2	Pharmaceutical PreparationsIBA 03/2020 - 11/2008
2	VenomsIBA 01/2018 - 01/2012
2	Carrier Proteins (Binding Protein)IBA 01/2018 - 08/2017
2	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 10/2017 - 02/2014
2	pertussis toxin-diphtheria toxin-tetanus toxin fusion proteinIBA 10/2017 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 08/2013 - 06/2003
2	Streptococcus pneumoniae plY proteinIBA 01/2013 - 03/2006
2	Immunoglobulin G (IgG)IBA 01/2012 - 02/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2008 - 02/2008
2	Recombinant ProteinsIBA 03/2006 - 03/2005
2	DNA VaccinesIBA 03/2006 - 09/2002
1	Interleukin-6 (Interleukin 6)IBA 05/2022
1	Epidermal Growth Factor (EGF)IBA 05/2022
1	Diphtheria-Tetanus-Pertussis Vaccine (DPT Vaccine)IBA 01/2021
1	ToxoidsIBA 01/2021
1	Tuberculosis VaccinesIBA 01/2021
1	Nucleic Acid-Based VaccinesIBA 11/2020
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 03/2020
1	Histone Deacetylases (Histone Deacetylase)IBA 03/2020
1	Polysaccharides (Glycans)IBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	EpitopesIBA 01/2020
1	PlasminogenIBA 01/2018
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2017
1	Conjugate VaccinesIBA 08/2017
1	Inactivated VaccinesIBA 01/2017
1	BCG Vaccine FDA Link 01/2017
1	Interleukin-17 (Interleukin 17)IBA 01/2017
1	E coli heat-labile enterotoxinIBA 01/2017
1	A-Form DNA (A-DNA)IBA 08/2013
1	Interleukin-5 (Interleukin 5)IBA 01/2012
1	Immunoglobulin E (IgE)IBA 01/2012
1	OvalbuminIBA 08/2010
1	Immunologic Factors (Immunomodulators)IBA 08/2010
1	Immunoglobulin A (IgA)IBA 02/2010
1	Lysine (L-Lysine)FDA Link 12/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2009
1	Influenza Vaccines (Influenza Vaccine)FDA Link 06/2009
1	Biomarkers (Surrogate Marker)IBA 06/2009
1	Interleukin-10 (Interleukin 10)IBA 11/2008
1	Complement System Proteins (Complement)IBA 04/2008
1	Pertussis VaccineIBA 02/2008
1	tetanus toxin fragment CIBA 01/2004
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2004

Therapy/Procedure

4	Immunotherapy 01/2021 - 11/2008
3	Therapeutics 01/2019 - 10/2006
2	Cautery 09/2010 - 11/2008
1	Drug Therapy (Chemotherapy) 03/2020
1	Intravesical Administration 01/2019
1	Microspheres (Microsphere) 08/2013